Clinical Trials Logo

Filter by:
NCT ID: NCT04180241 Active, not recruiting - Achalasia Clinical Trials

Development of Endoscopic Treatment for Achalasia

POEM
Start date: April 15, 2019
Phase: N/A
Study type: Interventional

Per Oral Endoscopic Myotomy (POEM); comparison of two surgical techniques division all the esophageal muscle layers versus division the inner circular muscle layer of the esophagus only.

NCT ID: NCT04343066 Active, not recruiting - Dental Implantation Clinical Trials

Bone Remodeling Around Implants With Two Different Surfaces Placed in Horizontally Augmented Bone

Start date: April 15, 2019
Phase: N/A
Study type: Interventional

The aim of this prospective controlled clinical trial is to evaluate the clinical and radiographical outcomes of two implant surfaces inserted in a crest that has been horizontally augmented at least 6 months prior to the implant placement. The horizontal GBR should be done with a xenogenic graft mixed with autologous bone particles, and a collagen membrane stabilized using tacks or screws.

NCT ID: NCT04532840 Active, not recruiting - Hypertrophic Scars Clinical Trials

Effect of Cryotherpy on Hypertrophic Scar

Start date: April 15, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

Purpose of the study: The purpose of the study is to evaluate the therapeutic effect of cryotherpy in treating hypertrophic scar. It will be hypothesized that: Cryotherapy may not have an effect on hypertrophic scar.

NCT ID: NCT04205929 Active, not recruiting - Bleeding Clinical Trials

Use of Curcumin to Treat Unfavorable Bleeding Patterns in Contraceptive Implant Users

Start date: April 15, 2020
Phase: Phase 4
Study type: Interventional

The investigators plan to study the effects of curcumin, the active ingredient in the spice turmeric, on the irregular bleeding experienced by women who use the contraceptive implant.

NCT ID: NCT04325217 Active, not recruiting - Clinical trials for Lung Diseases, Interstitial

Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan

Start date: April 15, 2020
Phase:
Study type: Observational

The primary objective is to confirm the incidence of adverse drug reactions (focus on gastrointestinal symptoms including diarrhoea and nausea) to Ofev Capsules seen in clinical trials with real world data generated in patients with SSc-ILD.

NCT ID: NCT04347239 Active, not recruiting - Clinical trials for Coronavirus Disease 2019

Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19)

Start date: April 15, 2020
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and efficacy of leronlimab (PRO 140) administered as weekly subcutaneous injection in subjects with severe or critical COVID-19 disease.

NCT ID: NCT04349540 Active, not recruiting - COVID19 Clinical Trials

Role of Immune and Inflammatory Response in Recipients of Allogeneic Haematopoietic Stem Cell Transplantation (SCT) Affected by Severe COVID19

(COVID19_BMT)
Start date: April 15, 2020
Phase:
Study type: Observational

COVID19 pandemic currently represents a public health emergency. Based on current data, 15% of the affected individuals will develop a severe form of the disease requiring admission to hospital and respiratory support. Data show that age and cardiovascular pre-existing comorbidities predict a poorer outcome. Some evidence suggests that a subset of patients with poorer outcome present with a cytokine mediated inflammatory response and with a secondary HLH like clinical phenotype. No data are so far available with regard to the risk of severe COVID19 disease in the post stem cell transplantation setting. Recipients of allogeneic stem cell transplantation are by definition immunologically dysregulated and could potentially present with a unique immune-inflammatory response to COVID 19 infection. Moreover, the immunosuppression used to prevent/treat GVHD may also impact clinical progression and it is possible that because of their immunological defects, SCT patients could potentially have prolonged carriage of the virus and hence act as "super spreaders". The present study aims at documenting clinical and biological characteristics, including immunological profiling, of allogeneic stem cell transplant recipients presenting with severe COVID 19 infection and its impact on patients survival. This work may provide the scientific basis for targeted therapy with biological agents in this patient group.

NCT ID: NCT04366154 Active, not recruiting - Cancer Clinical Trials

Impact of the COVID-19 Infectious Epidemic on the Management of Oncology and Onco-hematology Patients and on the Psychological Consequences for Patients and Caregivers

COVIPACT
Start date: April 15, 2020
Phase:
Study type: Observational

This original study will assess the impact of the coronavirus health crisis on the management of patients undergoing medical treatment for cancer, in particularly on the modification of the hospital organization. It will also provide a record of the progress of patients who will have been treated during the epidemic period and infected by the virus. We will also assess the psychological impact of the pandemic in patients but also in caregivers

NCT ID: NCT04768101 Active, not recruiting - Parkinson Disease Clinical Trials

Quantitative Imaging of Brain Glymphatic Function in Humans

Start date: April 15, 2020
Phase: Early Phase 1
Study type: Interventional

Recent immunological and physiological studies have provided evidence in support of a central nervous system (CNS) lymphatic drainage system in vertebrate animals, and preliminary evidence has suggested that a similar system exists in humans. If operative, this system may have central relevance to many vascular and fluid clearance disorders such as stroke, multiple sclerosis, Parkinson's disease, and Alzheimer's disease related dementia (ADRD): diseases which represent some of the most pressing healthcare challenges of the 21st century. Evaluating this possibility will require improved, robust imaging methods sensitive to lymphatic drainage dysfunction; as such, the goal of this work is to apply novel magnetic resonance imaging approaches, optimized already for evaluating lymphatic circulation in patients with peripheral lymphatic dysfunction, to quantify relationships between physiological hallmarks of ADRD and CNS lymphatic function in humans.

NCT ID: NCT04769297 Active, not recruiting - Clinical trials for Acute Stress Disorder

Micro-Dose, Macro-Impact: Leveraging Psychedelics in Frontline Healthcare Workers During the COVID-19 Pandemic

Start date: April 15, 2020
Phase: Phase 4
Study type: Interventional

A retrospective chart review of an open-label trial of low-dose ketamine administered to front-line Healthcare workers who were identified as experiencing acute stress disorder due to the COVID-19 Pandemic.